MAP3K5 (Ab-966) antibody is a rabbit polyclonal antibody specifically designed to recognize the phosphorylation site at Serine 966 of human Apoptosis Signal-regulating Kinase 1 (ASK1), also known as Mitogen-activated protein kinase kinase kinase 5 (MAP3K5). The antibody is generated using a synthesized peptide derived from the region surrounding amino acids 964-968 (S-I-S-L-P) of human ASK1 .
The epitope recognition is specific to the phosphorylated form of this serine residue, making this antibody particularly useful for studying the regulatory mechanisms of ASK1 through this specific post-translational modification.
MAP3K5/ASK1 functions as an essential component of the MAP kinase signal transduction cascade. It plays crucial roles in:
Mediating cellular responses to environmental changes
Signal transduction for cell fate determination including differentiation and survival
Apoptosis signal transduction through mitochondria-dependent caspase activation
Innate immune response essential for host defense against pathogens
Stress response signaling, particularly oxidative stress
Receptor-mediated inflammatory signal transduction (e.g., TNF, LPS)
When activated, MAP3K5/ASK1 functions as an upstream activator of MKK/JNK and p38 MAPK signaling cascades by phosphorylating and activating several MAP kinase kinases including MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6, and MAP2K7/MKK7 .
According to multiple sources, the MAP3K5 (Ab-966) antibody has been validated for the following applications:
| Application | Recommended Dilution | Notes |
|---|---|---|
| Western Blotting (WB) | 1:500-1:2000 | Verified with 293 cell samples |
| Immunohistochemistry (IHC-p) | 1:50-1:300 | Paraffin-embedded sections |
| Immunofluorescence (IF) | 1:100-1:200 | For cellular localization studies |
| ELISA | As recommended by manufacturer | For quantitative detection |
The antibody has been specifically verified in Western blotting applications using 293 cell lysates .
The MAP3K5 (Ab-966) antibody has been confirmed to react with:
Human
Mouse
Rat
This cross-species reactivity makes it valuable for comparative studies across different model systems .
For optimal antibody performance and longevity:
Store at -20°C or -80°C upon receipt for long-term storage
For frequent use and short-term storage (up to one month), the antibody can be kept at 4°C
Avoid repeated freeze-thaw cycles
The antibody is typically supplied in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150mM NaCl, 0.02% sodium azide, and 50% glycerol
Most formulations include stabilizers like 0.05% stabilizer and 0.5% protein protectant
Phosphorylation at Ser966 represents a key regulatory mechanism for MAP3K5/ASK1 activity. This specific modification occurs in response to various cellular stressors and affects protein-protein interactions critical for MAP3K5 function.
When Ser966 is phosphorylated, it promotes interaction with 14-3-3 proteins, which alters the subcellular distribution of MAP3K5/ASK1, restricting it to the perinuclear endoplasmic reticulum region. This sequestration effectively inhibits its kinase activity by preventing interaction with downstream targets .
In contrast to activating phosphorylation sites, Ser966 phosphorylation serves as an inhibitory modification that helps maintain MAP3K5/ASK1 in an inactive state under normal conditions. Understanding the balance between activating and inhibitory phosphorylation is crucial for interpreting experimental results.
To effectively detect Ser966 phosphorylation of MAP3K5/ASK1:
Cell stimulation conditions:
For basal phosphorylation: Serum-starve cells for 4-6 hours before harvesting
For induced dephosphorylation: Treat cells with oxidative stress inducers (H₂O₂, 0.5-1 mM for 15-30 minutes)
For increased phosphorylation: Growth factor stimulation (serum, EGF, or insulin)
Lysis buffer composition:
Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate)
Add protease inhibitors cocktail
Use RIPA or NP-40 based buffers with 1% detergent concentration
Sample preparation:
A robust experimental design when working with MAP3K5 (Ab-966) antibody should include:
Positive controls:
293 cell lysates (verified as a positive control in manufacturer validation)
Heart or pancreas tissue lysates (where MAP3K5 is abundantly expressed)
Cells treated with known activators of the ASK1 pathway
Negative controls:
MAP3K5/ASK1 knockdown or knockout samples
Competing peptide blocking experiments
Samples treated with lambda phosphatase to remove phosphorylation
Specificity controls:
Parallel blots with antibodies detecting total MAP3K5/ASK1
Comparison with antibodies targeting other phosphorylation sites on MAP3K5/ASK1
When encountering inconsistent results with the MAP3K5 (Ab-966) antibody in Western blotting applications:
| Issue | Potential Cause | Solution |
|---|---|---|
| No signal | Insufficient protein loading | Increase protein concentration (load 50-70 μg) |
| Phosphatase activity during preparation | Ensure proper phosphatase inhibitors are present | |
| Improper transfer | Optimize transfer conditions for high MW proteins (≈155 kDa) | |
| Multiple bands | Different modified forms of MAP3K5 | Expected; MAP3K5 can have multiple phosphorylation sites |
| Non-specific binding | Increase blocking time/concentration; optimize antibody dilution | |
| Incorrect molecular weight | Post-translational modifications | Expected; phosphorylation can alter migration |
| Proteolytic degradation | Add protease inhibitors during sample preparation | |
| Weak signal | Low expression levels | Enrich for phosphorylated proteins via immunoprecipitation |
| Suboptimal detection method | Consider switching to more sensitive detection systems |
Always verify the expected molecular weight of MAP3K5/ASK1, which is calculated to be approximately 155 kDa .
Detecting MAP3K5 Ser966 phosphorylation in tissue samples requires special considerations:
Tissue preparation:
Rapid fixation is critical to preserve phosphorylation status
For frozen sections, snap-freeze tissues immediately in liquid nitrogen
For FFPE samples, use 10% neutral buffered formalin with fixation time not exceeding 24 hours
Antigen retrieval optimization:
Test both heat-mediated (citrate buffer, pH 6.0) and enzymatic methods
For phospho-epitopes, EDTA-based retrieval (pH 9.0) often yields better results
Carefully monitor retrieval times to prevent epitope destruction
Signal amplification:
Consider using tyramide signal amplification for low abundance phosphoproteins
Polymer detection systems often provide better sensitivity than traditional ABC methods
Tissue-specific considerations:
To effectively use MAP3K5 (Ab-966) antibody in stress-response pathway studies:
Experimental design for pathway analysis:
Time-course experiments: Monitor Ser966 phosphorylation changes over time (0, 5, 15, 30, 60 min) following stress induction
Dose-response studies: Vary concentrations of stress inducers to determine threshold for Ser966 phosphorylation changes
Combinatorial stress experiments: Apply multiple stressors to evaluate interaction effects
Relevant stress inducers for MAP3K5/ASK1 studies:
Oxidative stress: H₂O₂ (0.5-1 mM), paraquat, menadione
Inflammatory stimuli: TNFα (10-50 ng/ml), IL-1β, LPS
ER stress: tunicamycin, thapsigargin
Genotoxic stress: UV irradiation, etoposide
Pathway validation approaches:
Pharmacological inhibitors: p38 MAPK inhibitors (SB203580), JNK inhibitors (SP600125)
Genetic manipulation: siRNA/shRNA against upstream regulators or downstream effectors
Correlation with downstream markers: monitor phosphorylation of p38 MAPK and JNK in parallel
Integration with other techniques:
MAP3K5/ASK1 contains multiple phosphorylation sites that regulate its activity in complex ways. To distinguish between different phosphorylation states:
Multi-antibody approach:
Use a panel of phospho-specific antibodies targeting different sites (S83, S966, T838, etc.)
Compare with total MAP3K5/ASK1 antibody to determine phosphorylation stoichiometry
Run parallel Western blots or use different fluorescent secondary antibodies for multiplexing
Phosphatase treatment controls:
Lambda phosphatase: Removes all phosphorylation
Serine/threonine-specific phosphatases: Can help distinguish between phospho-serine and phospho-threonine
Mass spectrometry-based approaches:
Immunoprecipitate MAP3K5/ASK1 and perform phosphopeptide mapping
Use MRM (Multiple Reaction Monitoring) for quantitative analysis of specific phosphorylation sites
Consider SILAC or TMT labeling for comparing phosphorylation across conditions
Phospho-mimetic and phospho-dead mutants:
Generate S966A (phospho-dead) and S966D/E (phospho-mimetic) mutants
Use these mutants as controls for antibody specificity and to study functional consequences
2D gel electrophoresis:
For comprehensive studies integrating MAP3K5 Ser966 phosphorylation status with functional activity:
Kinase activity assays:
In vitro kinase assays using immunoprecipitated MAP3K5/ASK1 and substrates like MKK4 or MKK6
Correlation of Ser966 phosphorylation status with kinase activity
ATP consumption assays as surrogate measures of kinase activity
Downstream pathway activation:
Monitor phosphorylation of direct MAP3K5 substrates (MAP2K4/MAP2K6)
Assess activation of downstream MAPKs (p38, JNK)
Evaluate transcriptional changes of known target genes
Cellular outcome measurements:
Apoptosis assays: Annexin V/PI staining, caspase activity, TUNEL assay
Cell cycle analysis to detect stress-induced cell cycle arrest
ROS measurement to correlate oxidative stress with Ser966 phosphorylation
Co-immunoprecipitation studies:
Investigate how Ser966 phosphorylation affects protein-protein interactions
Focus on known interaction partners like 14-3-3 proteins, TRAF2, TRAF6
Combine with proximity ligation assays for in situ interaction detection
Translocation analyses: